Discovery of SCH446211 (SCH6): a new ketoamide inhibitor of the HCV NS3 serine protease and HCV subgenomic RNA replication

J Med Chem. 2006 May 4;49(9):2750-7. doi: 10.1021/jm060077j.

Abstract

Introduction of various modified prolines at P(2) and optimization of the P(1) side chain led to the discovery of SCH6 (24, Table 2), a potent ketoamide inhibitor of the HCV NS3 serine protease. In addition to excellent enzyme potency (K(i)*= 3.8 nM), 24 was also found to be a potent inhibitor of HCV subgenomic RNA replication with IC(50) and IC(90) of 40 and 100 nM, respectively. Recently, antiviral activity of 24 was demonstrated with inhibition of the full-length genotype 2a HCV genome. In addition, 24 was found to restore the responsiveness of the interferon regulatory factor 3 (IRF-3) in cells containing HCV RNA replicons.

MeSH terms

  • Amides / chemistry*
  • Amides / pharmacology*
  • Animals
  • Genome, Viral / genetics*
  • Haplorhini
  • Hepacivirus / drug effects*
  • Hepacivirus / enzymology
  • Hepacivirus / genetics
  • Models, Molecular
  • Molecular Structure
  • Oligopeptides / chemistry*
  • Oligopeptides / pharmacology*
  • RNA, Viral / genetics
  • Rats
  • Serine Endopeptidases / chemistry
  • Serine Endopeptidases / metabolism*
  • Serine Proteinase Inhibitors / chemistry
  • Serine Proteinase Inhibitors / pharmacology
  • Viral Nonstructural Proteins / chemistry
  • Viral Nonstructural Proteins / metabolism

Substances

  • Amides
  • NS3 protein, hepatitis C virus
  • Oligopeptides
  • RNA, Viral
  • SCH6
  • Serine Proteinase Inhibitors
  • Viral Nonstructural Proteins
  • Serine Endopeptidases